What is the key to bridging the communication and trust gap between pharma and healthcare practitioners?

Previous scandals and improvements in standards and transparency mean that the conversations and exchanges of information that take place between pharmaceutical companies and healthcare practitioners (HCPs) are now closely regulated in many countries.

One of the most strictly regulated environments in this regard is in the UK, where all contact that takes place between companies and health professionals is subject to a strict code of practice.

Pharma companies have to make sure that the actions of their employees and their representatives are perfectly responsible and transparent to avoid breaching the regulations, which are administered by the Prescription Medicines Code of Practice Authority on behalf of the Association of the British Pharmaceutical Industry.